MARKET

EDSA

EDSA

Edesa Biotech Inc
NASDAQ
7.91
-0.29
-3.48%
Opening 09:51 06/29 EDT
OPEN
8.08
PREV CLOSE
8.19
HIGH
8.16
LOW
7.82
VOLUME
28.77K
TURNOVER
--
52 WEEK HIGH
20.32
52 WEEK LOW
0.7200
MARKET CAP
70.29M
P/E (TTM)
-5.8957
1D
5D
1M
3M
1Y
5Y
1D
Top Biotech Gainers: BOLD Begins Anew, MNPR NDA Filing On Track, GALT Soars On FDA Alignment
NASDAQ · 5d ago
Weekly Report: what happened at EDSA last week (0615-0619)?
Weekly Report · 06/22 09:11
Weekly Report: what happened at EDSA last week (0608-0612)?
Weekly Report · 06/15 09:10
Edesa Enters PIPE Placement Worth $3.5 Mln With Investors And CEO
NASDAQ · 06/12 10:57
Edesa Biotech Announces Insider-Led PIPE Financing Agreement
TipRanks · 06/11 13:49
Edesa Biotech announces $3.5M PIPE financing
Seeking Alpha · 06/11 13:45
Edesa Biotech announces $3.5M private placement
TipRanks · 06/11 13:27
Edesa Biotech plans $3.5 million unregistered share sale in PIPE financing
PUBT · 06/11 13:15
More
About EDSA
Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company developing ways to treat inflammatory and immune-related diseases. The Company’s clinical pipeline is focused on two therapeutic areas: medical dermatology and respiratory. In medical dermatology, the Company is developing EB06, an anti-CXCL10 monoclonal antibody candidate, as a therapy for vitiligo, a common autoimmune disorder that causes skin to lose its color in patches. Its medical dermatology assets also include EB01 (1.0% daniluromer cream), a Phase III-ready asset developed for use as a potential therapy for moderate-to-severe chronic allergic contact dermatitis (ACD), a common occupational skin condition. The Company’s advanced respiratory drug candidate is EB05 (paridiprubart), which is being evaluated in a United States government-funded platform study as a treatment for acute respiratory distress syndrome.

Webull offers Edesa Biotech Inc stock information, including NASDAQ: EDSA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EDSA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EDSA stock methods without spending real money on the virtual paper trading platform.